Leading Conference Organizer IMN Launches AI in Real Estate Conference on June 11 in New York City
April 17, 2024 09:00 ET
|
IMN
As AI innovations accelerate in the real estate sector, IMN’s debut conference will take place on June 11, 2024 at the Union League Club in NYC.
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results
March 11, 2024 16:05 ET
|
Ocular Therapeutix, Inc.
Leadership Appointments Move Ocular Towards Being a Leader in Retinal Care Screening Underway in AXPAXLI™ Phase 3 SOL-1 Trial for Wet AMD Topline Clinical Data for AXPAXLI in Diabetic Retinopathy...
Director Declaration
January 26, 2024 02:00 ET
|
ICG Enterprise Trust Plc
ICG Enterprise Trust plc (the “Company”) 26 January 2024 Director Declaration In accordance with the Financial Conduct Authority's Listing Rules, ICG Enterprise Trust plc announces that Alastair...
KBW Announces Index Rebalancing for Fourth-Quarter 2023
December 08, 2023 20:30 ET
|
Keefe, Bruyette & Woods, Inc. (KBW)
NEW YORK, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of...
Technicolor Creative Studios : Mise à disposition du projet de note en réponse
November 20, 2023 10:55 ET
|
Technicolor Creative Studios
COMMUNIQUÉ DU 20 NOVEMBRE 2023RELATIF AU DÉPÔT D’UN PROJET DE NOTE ÉTABLI PAR LA SOCIÉTÉ TECHNICOLOR CREATIVE STUDIOS EN RÉPONSE AU PROJET D’OFFRE PUBLIQUE D’ACHAT SIMPLIFIÉE VISANT LES ACTIONS DE...
(French only) Technicolor Creative Studios : Mise à disposition du projet de note en réponse
November 20, 2023 10:55 ET
|
Technicolor Creative Studios
(FRENCH ONLY) COMMUNIQUÉ DU 20 NOVEMBRE 2023RELATIF AU DÉPÔT D’UN PROJET DE NOTE ÉTABLI PAR LA SOCIÉTÉ TECHNICOLOR CREATIVE STUDIOS EN RÉPONSE AU PROJET D’OFFRE PUBLIQUE D’ACHAT SIMPLIFIÉE...
Ocular Therapeutix™ Provides Third Quarter 2023 Financial Results and Corporate Update
November 07, 2023 16:01 ET
|
Ocular Therapeutix, Inc.
FDA Agrees to Overall Design of the First Pivotal Trial for AXPAXLI in Wet AMD under a Special Protocol Assessment; Expect First Subject Dosed by Year-End Top-line Data from U.S.-based HELIOS Trial...
Ocular Therapeutix™ Provides Second Quarter 2023 Financial Results and Corporate Update
August 07, 2023 16:01 ET
|
Ocular Therapeutix, Inc.
DEXTENZA® Net Product Revenue in Q2 2023 was $15.0 million, Representing Growth of Approximately 24% Over Q2 2022 Closed on a New $82.5 million Credit Facility; Cash Runway Now Forecasted...
Self-storage Market Revenues to Reach USD 72.15 billion by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence
July 26, 2023 09:30 ET
|
Mordor Intelligence
Hyderabad, July 26, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled “Self-storage Market Report (2023-2028),” the market is estimated at USD 58.26 billion in 2023. It is...
Elis: Full-year 2022 results
March 08, 2023 01:00 ET
|
Elis
Very good 2022 performance: record revenue, EBITDA, EBIT and headline net result Marked pick-up in hospitality and satisfactory pricing adjustments in a context of high inflation Acceleration of...